J. Edwards

发表

A double blind controlled trial of methylprednisolone infusions in systemic lupus erythematosus using individualised outcome assessment.

D. Isenberg, M. Snaith, J. Edwards, 1987, Annals of the Rheumatic Diseases.

B cell depletion therapy in systemic lupus erythaematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response

D. Isenberg, W. Stohl, M. Leandro, 2007 .

Primary Sjögren ’ s syndrome associated with chronic periaortitis

G. Cambridge, S. M., D. Campbell, 2022 .

Clinical outcome following B cell depletion therapy in eight patients with refractory idiopathic inflammatory myopathy.

D. Isenberg, S. Sultan, G. Cambridge, 2008, Clinical and experimental rheumatology.

The synovial lining : in health and disease

B. Henderson, J. Edwards, 1987 .

Immunological changes associated with a successful outcome of pollen immunotherapy

B. Davies, R. Fifield, A. Fennerty, 1988, Allergy.

A double blind controlled trial ofmethylprednisolone infusions insystemic lupuserythematosus using individualised outcomeassessment

D. Isenberg, M. Snaith, J. Edwards, 1987 .

B lymphocyte depletion in patients with rheumatoid arthritis: Serial studies of immunological parameters.

Ehrenstein, M. Leandro, G. Cambridge, 2002 .

Serological changes following B cell depletion therapy in Systemic Lupus Erythematosus: Relationship with BLyS

Ehrenstein, D. Isenberg, D. Hilbert, 2004 .

B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients.

D. Isenberg, M. Leandro, M. Ehrenstein, 2005, Rheumatology.

B lymphocyte depletion therapy with rituximab in rheumatoid arthritis.

M. Leandro, J. Edwards, G. Cambridge, 2004, Rheumatic diseases clinics of North America.

TREATMENT OF REFRACTORY LUPUS NEPHRITIS WITH B LYMPHOCYTE DEPLETION

Ehrenstein, D. Isenberg, J. Manson, 2003 .